Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial
Adrian S. Dobs(Johns Hopkins University), Mitchell S. Steiner(Johns Hopkins University), C. Croot(North Mississippi Medical Center), Nashat Gabrail(Gabrail Cancer Center), Ralph V. Boccia(Center for Cancer and Blood Disorders), James T. Dalton(The Ohio State University), Michael L. Hancock(St. Jude Children's Research Hospital), Mary Ann Johnston
Cited by 387
Related Papers
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
|Breast Cancer Research and Treatment|2017|761
Acute Myeloid Leukemia in Children Treated with Epipodophyllotoxins for Acute Lymphoblastic Leukemia
|New England Journal of Medicine|1991|722
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia
|Blood|2000|475
Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia
|New England Journal of Medicine|2010|425
High incidence of secondary brain tumours after radiotherapy and antimetabolites
|The Lancet|1999|414